immunic-therapeutics.com (IMUX) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
The EV/EBITDA valuation dynamics, reaching 0.00, highlight the expenditure of accumulated funds on global drug trials. Immunic, Inc. (IMUX) develops oral treatments for autoimmune pathologies, minimizing supply risks through backup contracts. Additionally, the company is developing a multiple sclerosis therapy, where the requirement for lifelong medication guarantees the enterprise a highly sustainable cash flow.
immunic-therapeutics.com - analytical breakdowns and key metrics (IMUX)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
IMUX - Net Income|Future Profit Immunic, Inc.|IMUX - P/E Multiple|Future Price to Earnings Immunic|IMUX - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple IMUX|IMUX - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Immunic|IMUX - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months immunic-therapeutics.com|IMUX - Earnings per share increase in current year|Earnings growth forecast for next year Immunic, Inc.
Initial company analysis:Immunic Inc IMUX
This indicator compares the total enterprise value, including net debt, to earnings before interest, taxes, depreciation, and amortization, allowing for an assessment of the asset's real value regardless of the tax regime. For Immunic, Inc., which relies on third-party manufacturing capacities for drug production, the company's current EV/EBITDA multiple reflects capital management efficiency under outsourcing conditions, visualizing the investment attractiveness of the model.
Analysis of competing companies
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Dianthus Corp DNTH|Pharvaris N.V. (PHVS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio AbCellera|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tourmaline Bio|Enterprise Value to EBITDA Ratio Precigen Inc (PGEN)|Enterprise Value to EBITDA Ratio PHAR (Pharming)|EV/EBITDA Multiple Nektar Corp (NKTR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Upstream Bio Inc UPB|ZBIO: Enterprise Value to Operating Income Before Depreciation|Immunome - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Gossamer Bio Inc GOSS|KALV: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Septerna Pharma|Enterprise Value to EBITDA Ratio PVLA|SVRA: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple RIGL|Total Company Value to Operating Income Before Depreciation Ratio AnaptysBio Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Astria Pharma ATXS|ENGN: Enterprise Value to Operating Income Before Depreciation|RAPT Therapeutics - EV/EBITDA Multiple|Aerovate Therapeutics Inc (JBIO) - Enterprise Value to EBITDA Ratio|ACRS (Aclaris Therapeutics, Inc.) - Enterprise Value to EBITDA Ratio|KYTX - Total Company Value to Operating Income Before Depreciation Ratio|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|Cabaletta Bio Inc (CABA) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ventyx Biosciences (VTYX)|Enterprise Value to EBITDA Ratio theratech.com THTX|Avalo Therapeutics - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Eledon Pharmaceuticals Inc. ELDN|AGEN: Enterprise Value to EBITDA Ratio|CLYM (Climb Bio, Inc) - Enterprise Value to Operating Income Before Depreciation|Zura Bio (ZURA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio ATYR (atyrpharma.com)|ADAG (Adagene Inc) - EV/EBITDA Multiple|IMA: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple STTK|EV/EBITDA Multiple equilliumbio.com (EQ)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Connect Biopharma Holdings Limited CNTB|Business Value to Operating Income Before Depreciation ATRA|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|X4 Pharmaceuticals Inc. (XFOR) - Enterprise Value to EBITDA Ratio|ACET: EV/EBITDA Multiple|Celularity (CELU) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio INMB|BRNS: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple KZR|Total Company Value to Operating Income Before Depreciation Ratio SAB Biotherapeutics Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Akari Therapeutics plc AKTX|ENLV - Enterprise Value to EBITDA Ratio|QTTB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|geovax.com (GOVX) - Enterprise Value to EBITDA Ratio|EDSA (Edesa Biotech) - Enterprise Value to EBITDA Ratio|iBio Inc (IBIO) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|Enterprise Value to Operating Income Before Depreciation XTLB (XTL Bio)|EV/EBITDA Multiple BOLT|HCWB - Company Value to EBITDA|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|Total Company Value to Operating Income Before Depreciation Ratio aimimmuno.com (AIM)|ADTX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GRI Bio Corporation (GRI) - Enterprise Value to EBITDA Ratio|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio reshapelifesciences.com|Enterprise Value to EBITDA Ratio REVB|EV/EBITDA Multiple Indaptus Therapeutics Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|calcimedica.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AFMD (Affimed N.V.)|Total Company Value to Operating Income Before Depreciation Ratio Allakos Inc (ALLK)|HOOKIPA - EV/EBITDA Multiple|IGM Biosciences, Inc. (IGMS) - Enterprise Value to EBITDA Ratio|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|Ocean Biomedical Corp - Business Value to Operating Income Before Depreciation|TCBP (TC Biopharm) - EV/EBITDA Multiple|thirdharmonicbio.com (THRD) - Total Company Value to Operating Income Before Depreciation Ratio
